Annual report pursuant to Section 13 and 15(d)

Schedule of calculations of basic and diluted EPS (Details)

v3.22.2.2
Schedule of calculations of basic and diluted EPS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]    
Net income (loss) $ (566,000) $ 16,009,000
As reported, Weighted Average Shares Outstanding 29,187 23,230
Amounts allocated to unvested restricted shares $ 106
Weighted Average Shares Outstanding Amounts allocated to unvested restricted shares and warrants 154
Amounts allocated to unvested restricted shares $ (106)
Weighted Average Shares Outstanding Amounts allocated to unvested restricted shares and warrants (154)
Amounts available to common stockholders, Net Income (in Dollars) $ (566,000) $ 15,903,000
Amounts available to common stockholders, Weighted Average Shares 29,187  
Amounts available to stockholders and assumed conversions, Earnings Loss Per Share $ (0.02) $ 0.69
Amounts available to common stockholders, Weighted Average Shares 29,187 23,076
Amounts allocated to unvested restricted shares, Net Income $ 106,000
Amounts allocated to unvested restricted shares, Weighted Average Shares Outstanding 154
Stock warrants
Weighted Average Shares Outstanding Stock warrants
Incremental Shares to Be Issued For Convertible Note Related Party Net Loss  
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities  
Amounts reallocated to unvested restricted shares, Net Income $ (107,000)
Amounts reallocated to unvested restricted shares, Weighted Average Shares Outstanding
Amounts available to stockholders and assumed conversions, Net Income $ (566,000)  
Amounts available to stockholders and assumed conversions, Weighted Average Shares Outstanding 29,187 23,230
Amounts available to stockholders and assumed conversions, Net income   $ 15,902,000